Geode Capital Management’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$513K Sell
32,047
-3,378
-10% -$43.5K ﹤0.01% 3590
2026
Q1
$318K Buy
35,425
+4,424
+14% +$30.2K ﹤0.01% 3753
2025
Q4
$170K Buy
31,001
+375
+1% +$1.93K ﹤0.01% 3965
2025
Q3
$122K Hold
30,626
﹤0.01% 4077
2025
Q2
$82.8K Sell
30,626
-318
-1% -$843 ﹤0.01% 4112
2025
Q1
$162K Sell
30,944
-34
-0.1% -$215 ﹤0.01% 3906
2024
Q4
$238K Buy
30,978
+355
+1% +$2.97K ﹤0.01% 3844
2024
Q3
$287K Buy
30,623
+3,122
+11% +$30.1K ﹤0.01% 3783
2024
Q2
$295K Sell
27,501
-37,455
-58% -$508K ﹤0.01% 3776
2024
Q1
$961K Buy
64,956
+1,798
+3% +$25.1K ﹤0.01% 3373
2023
Q4
$1.21M Buy
63,158
+876
+1% +$21.4K ﹤0.01% 3285
2023
Q3
$1.68M Buy
62,282
+611
+1% +$26.5K ﹤0.01% 3129
2023
Q2
$2.79M Buy
61,671
+16,201
+36% +$794K ﹤0.01% 3000
2023
Q1
$2.08M Buy
45,470
+8,085
+22% +$418K ﹤0.01% 3007
2022
Q4
$1.96M Buy
37,385
+4,670
+14% +$276K ﹤0.01% 3050
2022
Q3
$3.79M Buy
32,715
+8,489
+35% +$756K ﹤0.01% 2816
2022
Q2
$1.46M Sell
24,226
-3,153
-12% -$237K ﹤0.01% 3239
2022
Q1
$1.53M Buy
27,379
+13,124
+92% +$1.09M ﹤0.01% 3397
2021
Q4
$1.09M Buy
14,255
+5,510
+63% +$641K ﹤0.01% 3682
2021
Q3
$1.23M Buy
+8,745
New +$1.03M ﹤0.01% 3578

Other funds holding RLYB

Geode Capital Management's RLYB Position: Q2 2026 in Review

Geode Capital Management reduced its Rallybio (RLYB) stake by 9.5% in Q2 2026, selling an estimated $43.5K and leaving 32,047 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Geode Capital Management first reported a position in RLYB in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.79M in Q3 2022. 29 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Geode Capital Management held 32,047 shares of Rallybio worth $513K as of Q2 2026.
  • Geode Capital Management sold 3,378 Rallybio shares in Q2 2026, an estimated $43.5K.
  • Rallybio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3590 holding.
  • Geode Capital Management first reported a position in Rallybio in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Rallybio position peaked at $3.79M in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.